In conclusion, our investigation offers groundbreaking perspectives on Type 2 biomarkers within an East Asian bronchiectasis cohort, demonstrating the differential roles of BEC, FeNO, and serum IgE in influencing exacerbation risk. This evidence concerns the gene IGHE and bronchiectasis.